Rhythm Pharmaceuticals, Inc.【RYTM】 業績推移・財務諸表

機能の使い方
(単位:千ドル) 3Q17 4Q17 1Q18 2Q18 3Q18 4Q18 1Q19 2Q19 3Q19 4Q19 1Q20 2Q20 3Q20 1Q21 2Q21 3Q21 1Q22 2Q22 3Q22 1Q23 2Q23 3Q23 1Q24 2Q24 3Q24 1Q25 2Q25
売上高 - - - - - - - - - - - - - 35 274 1,028 1,498 - - 11,469 19,221 22,504 25,967 29,078 33,251 32,704 48,502
売上成長率(%) - - - - - - - - - - - - - - - - - - - - 126.4 51.3 47.8 25.9 66.8
売上原価 - - - - - - - - - - - - - 4 137 222 230 378 497 1,421 2,236 2,412 2,807 2,947 3,828 3,648 5,543
研究開発費 5,971 - 12,286 8,584 10,705 - 22,761 35,308 26,572 - 22,504 22,997 22,995 19,911 25,104 27,539 32,510 31,456 21,116 37,945 33,543 33,570 128,665 30,194 37,931 36,973 42,308
販売管理費 - - 4,715 6,437 8,539 - 7,759 8,841 10,535 - 12,796 8,921 11,289 14,518 15,465 17,507 21,449 22,328 21,938 24,634 30,046 30,475 34,382 36,415 35,377 39,087 45,947
営業利益率 (%) - - - - - - - - - - - - - - - -538.7 -139.2 -132.0 -143.7 -93.4
営業利益 -8,286 - -17,001 -15,021 -19,244 - -30,520 -44,149 -37,107 - -35,300 -31,918 -34,284 -34,398 -40,432 -44,240 -52,691 -45,096 -39,267 -52,531 -46,604 -43,953 -139,887 -40,478 -43,885 -47,004 -45,296
営業費用 8,286 10,983 17,001 15,021 19,244 27,151 30,520 44,149 37,107 34,224 35,300 31,918 34,284 34,433 40,706 45,268 54,189 54,162 43,551 64,000 65,825 66,457 165,854 69,556 77,136 79,708 93,798
経常(税引前)利益 - - - - - - - - - - - - - 65,756 -40,411 - - - - - - -43,795 -141,072 -31,782 -43,985 -49,418 -46,295
経常(税引前)利益率(%) - - - - - - - - - - - - - 187874.3 -14748.5 - - - - - - -194.6 -543.3 -109.3 -132.3 -151.1 -95.4
法人税等合計 - - - - - - - - - - - - - 22,006 -5,022 -8,995 0 - - - - 368 300 479 -344 80 300
実効税率(%) - - - - - - - - - - - - - - - - - - - -0.2 -1.5 0.8 -0.2 -0.6
純利益 -10,016 -10,531 -16,459 -14,412 -17,686 -25,507 -28,974 -42,796 -36,003 -32,956 -34,164 -31,117 -33,818 43,750 -35,389 -35,107 -52,764 -45,001 -40,861 -52,179 -46,703 -44,163 -141,372 -32,261 -43,641 -49,498 -46,632
純利益率(%) - - - - - - - - - - - - - - - -544.4 -110.9 -131.2 -151.4 -96.1
一株あたり利益 - - - - - - - - - - - - - 0.92 -0.7 - -1.05 -0.89 -0.79 -0.92 -0.82 -0.76 -2.35 -0.55 -0.73 -0.81 -0.75
希薄化後一株あたり利益 - - - - - - - - - - - - - 0.9 -0.7 - -1.05 -0.89 -0.79 -0.92 -0.82 -0.76 -2.35 -0.55 -0.73 -0.81 -0.75
EBITDA - - - - - - - - - - - - - - - - - - - - - - -
EBITDAマージン(%) - - - - - - - - - - - - - - - - - - - - - - - - - -